Photons, Protons, SBRT, Brachytherapy—What Is Leading the Charge for the Management of Prostate Cancer? A Perspective From the GU Editorial Team-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Photons, Protons, SBRT, Brachytherapy—What Is Leading the Charge for the Management of Prostate Cancer? A Perspective From the GU Editorial Team

Published:2021-07 Issue:4 Volume:110 Page:1114-1121
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Choudhury Ananya,Henry, MD, FRCR Ann,Mitin, MD, PhD Timur,Chen, MD, MPH Ronald,Joseph, MD, FRCR Nuradh,Spratt, MD, PhD Daniel E.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference44 articles.

1. 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer;Hamdy;N Engl J Med,2016

2. ProtecTing low-risk prostate cancer;Choudhury;Int J Radiat Oncol Biol Phys,2017

3. Proton radiation as boost therapy for localized prostatic carcinoma;Shipley;JAMA,1979

4. Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: A treatment planning comparison;Trofimov;Int J Radiat Oncol Biol Phys,2007

5. Proton versus photon-based radiation therapy for prostate cancer: Emerging evidence and considerations in the era of value-based cancer care;Kamran;Prostate Cancer Prostatic Dis,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of toxicities between ultrahypofractionated radiotherapy versus brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer;Scientific Reports;2022-03-23

2. Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer;Cancers;2021-12-31

3. Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300;Frontiers in Oncology;2021-11-17

4. In Regard to Choudhury et al.;International Journal of Radiation Oncology*Biology*Physics;2021-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3